Artelo Biosciences Inc (ARTL)

Finanzdaten der Artelo Biosciences Inc-Aktie (ARTL)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	23.95% 3.24	2.614	1.784	2.292	3.476
Interest Income/Expense	-	-	-	-	-
Operating Income/Loss	23.95% -3.24	-2.614	-1.784	-2.292	-3.476
Nonoperating Income/Loss	1.21% 0.167	0.165	0.185	0.124	0.137
Income/Loss From Continuing Operations Before Tax	533.12% -15.51	-2.449	-1.599	-2.168	3.339
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	533.12% -15.51	-2.449	-1.599	-2.168	3.339
Net Income/Loss	533.12% -15.51	-2.449	-1.599	-2.168	3.339
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-12.43	-	-	-	6.678
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-